What's in Rochester Center for Behavioral Medicine's pipeline?

Rochester Center for Behavioral Medicine has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Rochester Center for Behavioral Medicine's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, BRC Operations Pty. Ltd., Massachusetts General Hospital, NYU Langone Health, Novartis.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rochester-center-for-behavioral-medicine.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Rochester Center for Behavioral Medicine — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rochester Center for Behavioral Medicine pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Solriamfetol Oral Tablet [Sunosi]	Solriamfetol Oral Tablet [Sunosi]	marketed	Dopamine and norepinephrine reuptake inhibitor	Dopamine transporter (DAT) and norepinephrine transporter (NET)	Neurology / Sleep Medicine
Placebo "30, 50 or 70 mg"	Placebo "30, 50 or 70 mg"	marketed			Psychiatry/Behavioral Medicine
Dyanavel XR	Dyanavel XR	marketed	Sympathomimetic amine; CNS stimulant	Dopamine transporter (DAT); Norepinephrine transporter (NET)	Psychiatry / Neurology

Therapeutic area mix

Neurology / Sleep Medicine · 1
Psychiatry / Neurology · 1
Psychiatry/Behavioral Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
BRC Operations Pty. Ltd. · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
NYU Langone Health · 1 shared drug class
Novartis · 1 shared drug class
Rhodes Pharmaceuticals, L.P. · 1 shared drug class
Rush University Medical Center · 1 shared drug class
Seattle Children's Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Rochester Center for Behavioral Medicine:

Cite this brief

Drug Landscape (2026). Rochester Center for Behavioral Medicine — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rochester-center-for-behavioral-medicine. Accessed 2026-05-16.